Overview

Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is the first time finafloxacin was administered to humans intravenously. The principal aim of this study was to obtain safety and tolerability data when finafloxacin was administered intravenously as single and multiple doses to healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Treatments:
Finafloxacin
Fluoroquinolones
Pharmaceutical Solutions